4月16日电，港股医药股持续走弱，歌礼制药跌超10%，药明生物跌超5%。

Group 1 - The Hong Kong pharmaceutical sector is experiencing a decline, with notable drops in stock prices for companies such as Gilead Sciences, which fell over 10%, and WuXi Biologics, which decreased by more than 5% [1]